Expression of PD-L1 in Urothelial Carcinoma and its Association with Clinicopathological Parameters by Gurupriya Anand, HARJOT KAUR, Tejinder Singh Bhasin

Subjects: Get full text

Programmed death-ligand 1 expression and its correlation with clinicopathological parameters in gallbladder cancer by Ji Hye Kim, Kyungbin Kim, Misung Kim, Young Min Kim, Jae Hee Suh, Hee Jeong Cha, Hye Jeong Choi

Subjects: Get full text

Significance of infiltration of M1 tumor-associated macrophages in hepatocellular carcinoma by XIAO Feng, XU Tonglin, ZHU Lin, XIAO Jingwen, WU Tianqi, GU Chunyan

Subjects: “…|macrophage|programmed death ligand 1|hepatocellular carcinoma|prognosis…”
Get full text

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma by Yabing Cao, Kin Iong Chan, Gungli Xiao, Yanqun Chen, Xibin Qiu, Hu Hao, Sao Chi Mak, Tongyu Lin

Subjects: Get full text

Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma by Meiyan Zhu, Meng Jin, Xiao Zhao, Shunli Shen, Yihan Chen, Han Xiao, Guangyan Wei, Qiang He, Bin Li, Zhenwei Peng

Subjects: Get full text

Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer by Se Jun Park, Ju Yeon Park, Kabsoo Shin, Tae Ho Hong, MyungAh Lee, Younghoon Kim, In-Ho Kim

Subjects: Get full text

Remarkable response to pembrolizumab with platinum‐doublet in PD‐L1‐low pulmonary sarcomatoid carcinoma: A case report by Hirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, Noritaka Honda, Takayuki Suyama, Yasuhiro Umeyama, Yosuke Dotsu, Takumi Nakao, Kojima Tomohito, Hiroshi Gyotoku, Hiroyuki Yamaguchi, Taiga Miyazaki, Noriho Sakamoto, Yasushi Obase, Minoru Fukuda, Junya Fukuoka, Hiroshi Mukae

Subjects: Get full text

Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation by Toko Kumeta, Kei Yamaguchi, Ryosuke Hayami, Kazumori Arai, Michiko Tsuneizumi, Ryoichi Matsunuma

Subjects: Get full text

Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer by Chih‐Hung Chung, Chun‐Yu Lin, Chih‐Yu Chen, Chun‐Wei Hsueh, Yao‐Wen Chang, Chen‐Chi Wang, Pen‐Yuan Chu, Shyh‐Kuan Tai, Muh‐Hwa Yang

Subjects: Get full text

Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplex by Jinlin Zhang, Mingyue Wang, Doudou He, Liang Zhang, Tianqing Liu, Kaikai Wang

Subjects: Get full text

Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer by Setyo Teguh Waluyo, Brahmana Askandar Tjokroprawiro, Anny Setijo Rahaju

Subjects: “…Endometrial cancer, programmed death ligand-1…”
Get full text

PD-L1 Assessment in Needle Core Biopsies of Non-Small Cell Lung Cancer: Interpathologist Agreement and Potential Associated Histopathological Features by Ezgi HACIHASANOGLU, Buket BAMBUL SIGIRCI, Gamze USUL, Taha Cumhan SAVLI

Subjects: “…programmed death ligand 1…”
Get full text

The prognostic implications of podoplanin in cancer‐associated fibroblasts and PD‐L1 expression in high‐grade neuroendocrine carcinoma of the lung by Tatsuya Miyamoto, Tomohiro Haruki, Karen Makishima, Shinji Matsui, Yuki Oshima, Yoshihisa Umekita, Hiroshige Nakamura

Subjects: Get full text

Expression of chemokine CXCL5 and programme death ligand 1 in colorectal cancer tissues are associated with prognosis of patients by LIU Shiguang, ZHAO Jingkun, LU Aiguo, MAO Zhihai

Subjects: “…|colorectal cancer|cxcl5|programmed death ligand 1…”
Get full text

Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells by Rachel M. Gibbons Johnson, Haidong Dong, Haidong Dong

Subjects: Get full text

A study on expression of programmed death ligand-1 in small cell lung carcinoma and correlation with clinicopathological parameters by Sudha Sudha, Saumya Shukla, Nuzhat Husain, Hemant Kumar, Rahul Kumar Pandey, Surya Kant

Subjects: Get full text

Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients by Zhong J, Luo C, Zhang C, Li L

Subjects: Get full text

Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients by Jun Wang, Hongliang Zhang, Xin Sun, Xiaofang Wang, Tingting Ren, Yi Huang, Ranxin Zhang, Bingxin Zheng, Wei Guo

Subjects: Get full text

Emerging role of the immunotherapy in treatment of breast cancer by Nagwa Abd El-Sadek Ahmed*, Maisa Hashem Mohammed

Subjects: “…tnbc; immunotherapy; programmed death 1; programmed death ligand 1…”
Get full text

Immunohistochemical Expression of PD-L1 in Core Biopsy Samples of Non Small Cell Lung Cancer and its Association with Histopathological and Clinicoradiological Parameters by Swagata Karan, Prajna Das, Ranjita Panigrahi, C Mohan Rao

Subjects: Get full text